Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immune-mediated inner ear disease.

J H Stone1, H W Francis

  • 1Division of Rheumatology, Johns Hopkins Vasculitis Center, Johns Hopkins Medical Institutions, Baltimore, MD, USA. jstone@welch.jhu.edu

Current Opinion in Rheumatology
|January 27, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoimmune blistering diseases treated with glucocorticoids: An international study of steroid-induced myopathy.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

The Role of Quantification of Glucocorticoid-associated Toxicity in Severe Asthma.

Journal of cellular immunology·2021
Same author

Risk of hearing loss among multidrug-resistant tuberculosis patients according to cumulative aminoglycoside dose.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2020
Same author

Clinical features and mechanistic insights regarding IgG4-related dacryoadenitis and sialoadenitis: a review.

International journal of oral and maxillofacial surgery·2019
Same author

Immunoglobulin (Ig)M antibodies to proteinase 3 in granulomatosis with polyangiitis and microscopic polyangiitis.

Clinical and experimental immunology·2017
Same author

Treatment of IgG4-related disease : Current and future approaches.

Zeitschrift fur Rheumatologie·2016
Same journal

New approaches to the management of cutaneous lupus.

Current opinion in rheumatology·2026
Same journal

"Updates in chronic nonbacterial osteomyelitis: emerging insights across the age spectrum".

Current opinion in rheumatology·2026
Same journal

Difficult-to-treat, complex-to-manage, treatment-refractory spondyloarthritis: semantics or substance?

Current opinion in rheumatology·2026
Same journal

Update on IgA nephropathy: implications for treatment in IgA vasculitis: a guide for rheumatologists.

Current opinion in rheumatology·2026
Same journal

Polyarticular juvenile idiopathic arthritis: insights from genetic studies on disease risk and pathogenesis.

Current opinion in rheumatology·2026
Same journal

Immune dysregulation in children with Down syndrome: clinical implications and emerging therapies.

Current opinion in rheumatology·2026
See all related articles

Immune-mediated inner ear disease (IMIED) causes sudden hearing loss, vertigo, and tinnitus. Prompt immunosuppression can prevent severe outcomes, but its mechanisms require further study.

Area of Science:

  • Otolaryngology
  • Immunology
  • Rheumatology

Background:

  • Immune-mediated inner ear disease (IMIED) presents as subacute sensorineural hearing loss, often with vertigo and tinnitus.
  • IMIED can be a primary condition or secondary to systemic autoimmune diseases like lupus or Wegener's granulomatosis.
  • The exact pathological mechanisms of IMIED are not fully understood due to challenges in obtaining tissue samples from untreated patients.

Purpose of the Study:

  • To review the pathophysiology, clinical evaluation, diagnostic testing, and therapeutic strategies for IMIED.
  • To highlight the importance of early diagnosis and treatment in managing IMIED.
  • To provide a comprehensive overview of current knowledge regarding IMIED.

Main Methods:

  • Literature review of existing studies on IMIED.

Related Experiment Videos

  • Analysis of clinical presentations and diagnostic approaches.
  • Evaluation of immunosuppressive treatment protocols and outcomes.

    • Main Results:

    • IMIED is characterized by rapid onset hearing loss and vestibular symptoms.
    • Systemic autoimmune conditions are frequently associated with IMIED.
    • Early and aggressive immunosuppressive therapy is crucial for preserving hearing and vestibular function.

    Conclusions:

    • Prompt diagnosis and aggressive immunosuppression are vital to mitigate the severe consequences of IMIED.
    • Further research into IMIED pathophysiology is needed to improve treatment strategies.
    • A multidisciplinary approach involving otolaryngology, rheumatology, and immunology is beneficial for managing IMIED.